Effects of Ethanol on the Pharmacokinetics of PT-150 (Formerly ORG34517) (PT150 PK Study)
Status:
Not yet recruiting
Trial end date:
2022-03-31
Target enrollment:
Participant gender:
Summary
The purpose of this clinical study is to assess pharmacokinetic interactions between ethanol
(EtOH) and PT150 (900 mg qd) in non-treatment-seeking alcohol-experienced volunteers-(to
include military service members, veterans and/or civilians).
Phase:
Phase 1
Details
Lead Sponsor:
Pop Test Oncology LLC
Collaborators:
Baylor College of Medicine Congressionally Directed Medical Research Programs Michael Debakey Veterans Affairs Medical Center Michael E. DeBakey VA Medical Center Pharmacotherapies for Alcohol and Substance Abuse Consortium